• Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

    Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

  • Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

    The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

  • Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

    Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

  • Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

    The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

  • Visiongain Publishes Vaccine Delivery Devices Market Report 2021-2031

    Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of vaccine delivery devices in North America region are some of the major factors that propel the vaccine delivery devices market growth.